Clinical performance and quality measures for heart failure management in China: the China-Heart Failure registry study.

ESC Heart Fail · 2023 · PMC9871659 · PMID 36224725

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

From 2017 to 2020 in China‐HF stage II, the rates for the total RAS inhibitors and ARNI utilization also showed a trend of steadily increasing, whereas the trend of change for diuretics, beta‐blockers, and spironolactone did not reach a statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.